↓ Skip to main content

Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies

Overview of attention for article published in Frontiers in Pharmacology, September 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies
Published in
Frontiers in Pharmacology, September 2017
DOI 10.3389/fphar.2017.00662
Pubmed ID
Authors

Mihajlo Jakovljevic, Tetsuji Yamada

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 14%
Student > Postgraduate 3 8%
Student > Ph. D. Student 3 8%
Researcher 2 6%
Professor 2 6%
Other 7 19%
Unknown 14 39%
Readers by discipline Count As %
Medicine and Dentistry 6 17%
Social Sciences 4 11%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Engineering 2 6%
Economics, Econometrics and Finance 2 6%
Other 3 8%
Unknown 16 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2017.
All research outputs
#14,955,443
of 23,002,898 outputs
Outputs from Frontiers in Pharmacology
#5,286
of 16,309 outputs
Outputs of similar age
#188,577
of 318,503 outputs
Outputs of similar age from Frontiers in Pharmacology
#88
of 275 outputs
Altmetric has tracked 23,002,898 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,309 research outputs from this source. They receive a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,503 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 275 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.